I2O Therapeutics receives strategic investment from Colorcon Ventures


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ I2O Therapeutics receives strategic investment from Colorcon Ventures
Colorcon will collaborate with i2O to accelerate i2O’s research and development efforts

i2O Therapeutics, an innovative biotech company developing a platform to enable oral delivery of traditionally injectable biological drugs, has received a strategic investment from Colorcon Ventures, the corporate venture fund of Colorcon Inc. In addition to this investment, Colorcon will collaborate with i2O to accelerate i2O’s research and development efforts. i2O previously announced its seed round of financing led by Sanofi Ventures and JDRF T1D Fund in April 2020.

“We welcome Colorcon Ventures as a strategic investor at this pivotal time of company growth,” said Ravi Srinivasan, Ph.D., Chief Executive Officer of i2O Therapeutics.

Founded by a team of researchers from Harvard University, i2O Therapeutics is focused on the development of safe and effective oral formulations of therapies that are conventionally limited to injections, e.g. biologics, large molecules, and peptide-based pharmaceuticals such as insulin. The company’s innovative platform enables drugs that traditionally would not survive the hostile environment of the digestive system to pass through safely by utilizing a unique coating that dissolves in the small intestine, thereby releasing the active drug. i2O’s initial focus is on developing a novel oral formulation for GLP-1 analogs.

“We are excited to collaborate with Colorcon to help advance our ionic liquid technology given their rich history of innovation and expertise in pharmaceutical development,” said Samir Mitragotri, Ph.D., Co-founder of i2O Therapeutics.

“Colorcon Ventures’ strategic focus on technologies that transform conventional delivery pathways aligns well with i2O. The ability to deliver injectable therapies orally has the potential to significantly improve patient adherence and outcomes,” commented Martti Hedman, Colorcon’s Chief Executive Officer.

Dr Ali Rajabi-Siahboomi, Chief Scientific Officer of Colorcon states, “Colorcon's excipients and in-depth pharmaceutical development expertise will help advance the use of ionic liquids for the oral delivery of challenging molecules.”

Tags : #i20Therapeutics #LatestNewsini20Therapeutics4thDec #LatestPharmaNews4thDec #ColorconVentures #HarvardUniversity

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India on the Boil: Unmasking the Heatwave Crisis and the Cooling Power of Traditional WisdomApril 25, 2025
The Creamy Culprit: How Raw Egg Mayonnaise Became a Public Health Hazard in IndiaApril 25, 2025
The Invisible Childhood Enemy Behind Young Adult Colon CancerApril 25, 2025
TERN Group charts the future of ethical nurse migration with scalable impact.April 25, 2025
6 Gut-Friendly Foods That Soothe an Irritated StomachApril 25, 2025
Top 5 IVF Centres in India – Best IVF Clinics for Fertility TreatmentApril 25, 2025
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025April 25, 2025
World Malaria Day: Why India Must Not Let Its Guard DownApril 25, 2025
Murder in the Name of God: Kashmir and the Collapse of HumanityApril 24, 2025
6 Early Warning Signs of Malaria You Shouldn’t IgnoreApril 24, 2025
World Meningitis Day: A Loud Alarm for a Quiet KillerApril 24, 2025
Amid Documented Progress, India’s Malaria-Free Dream Faces Ground Realities.April 24, 2025
Medanta Surgeons Remove Rare Tumour, Rebuild Face of Iraqi Toddler in 14-Hour Surgery.April 24, 2025
Burnett Homeopathy Hosts Historic World Homeopathy Summit 3 During World Homeopathy Week in Germany April 24, 2025
Mind Over Meltdown: The Underrated Skill Saving Relationships and SanityApril 23, 2025
Moscow Accelerates AI Testing in Healthcare with New Diagnostic MethodApril 23, 2025
The Weight Loss Drug That Could Weigh Down Your Mind: A Closer Look at Ozempic’s Hidden CostApril 23, 2025
The Chaos That Makes You Human: How Disorder in the Brain Creates Order in ThoughtApril 23, 2025
Benefiting 7,000 Children Across 30 Schools with CSR InitiativesApril 23, 2025
MGM Healthcare Performs Life-Saving Surgery on 6-Year-Old Boy with Severe Heart BlockageApril 23, 2025